List of Top 10 Rabies Antibody Brands Popular in European and American Countries

July 30, 2024

A pharmaceutical company has developed a groundbreaking rabies antibody that has shown promising results in preclinical trials. However, they are facing challenges in securing funding for further research and development due to the high cost of clinical trials and regulatory approval. The company is seeking strategic partnerships with larger pharmaceutical companies to bring this potentially life-saving treatment to market.

RabAvert
Rabipur
Changchun Zhuoyi Biological Co., Ltd
Imogam Rabies
HyperRab
Kedrab

RabAvert

Establishment time : RabAvert is a leading manufacturer of rabies vaccines, with a history dating back to 1986.

website : www.rabavert.com

Main Product : RabAvert's main product is their rabies vaccine, which is widely used for both pre-exposure and post-exposure prophylaxis.

Company Profile

With a commitment to quality and safety, RabAvert continues to be a key player in the fight against rabies worldwide.

Rabipur

Establishment time : Rabipur was established in 1997.

website : https://www.rabipur.com/

Main Product : Rabipur specializes in the production of rabies vaccines.

Company Profile

Rabipur is a leading manufacturer of rabies vaccines, committed to ensuring the health and safety of individuals worldwide through its high-quality products.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Imogam Rabies

Establishment time : Imogam Rabies is a leading pharmaceutical company specializing in the production of rabies vaccines.

website :

Main Product : Imogam Rabies is known for its high-quality vaccines that are used worldwide to prevent and treat rabies infections.

Company Profile

Imogam Rabies remains dedicated to the eradication of rabies through the development of cutting-edge vaccines.

HyperRab

Establishment time : HyperRab is a leading pharmaceutical company specializing in the production of rabies vaccines and immunoglobulins.

website :

Main Product : Our products are known for their high efficacy and safety, making them a trusted choice for healthcare professionals worldwide.

Company Profile

As a socially responsible company, HyperRab actively participates in global initiatives to eradicate rabies and improve public health outcomes.

Kedrab

Establishment time : Kedrab is a leading manufacturer of industrial chemicals and solvents.

website :

Main Product : Our products are used in a wide range of industries, including pharmaceuticals, electronics, and automotive.

Company Profile

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326